Skip to content
Open access · CC-BY via OpenAlex

Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labeling

Guoyun Kao, Xiaonan Zhang, Fariborz Nasertorabi, Benjamin B. Katz, Zeyang Li, Zhefu Dai, Zeyu Zhang, Lei Zhang, Stan G. Louie, Vadim Cherezov, Yong Zhang

JACS Au · 2024 · ▲ 9 citations

Abstract

High Resolution Image Download MS PowerPoint Slide Nicotinamide adenine dinucleotide (NAD + ) is required for a myriad of metabolic, signaling, and post-translational events in cells. Its levels in tissues and organs are closely associated with health conditions. The homeostasis of NAD + is regulated by biosynthetic pathways and consuming enzymes. As a membrane-bound protein with robust NAD + hydrolase activity, cluster of differentiation 38 (CD38) is a major degrader of NAD + . Deficiency or inhibition of CD38 enhances NAD + levels in vivo, resulting in various therapeutic benefits. As a metabolic precursor of NAD +, nicotinamide mononucleotide can be rapidly hydrolyzed by CD38, whereas nicotinamide riboside (NR) lacks CD38 substrate activity. Given their structural similarities, we explored the inhibition potential of NR. To our surprise, NR exhibits marked inhibitory activity against CD38 by forming a stable ribosyl–ester bond with the glutamate residue 226 at the active site. Inspired by this discovery, we designed and synthesized a clickable NR featuring an azido substitution at the 5′-OH position. This cell-permeable NR analogue enables covalent labeling and imaging of both extracellular and intracellular CD38 in live cells. Our work discovers an unrecognized molecular function of NR and generates a covalent probe for health-related CD38. These findings offer new insights into the role of NR in modulating NAD + metabolism and CD38-mediated signaling as well as an innovative tool for in-depth studies of CD38 in physiology and pathophysiology.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1021/jacsau.4c00695
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Kao, G., Zhang, X., Nasertorabi, F., Katz, B.B., Li, Z., Dai, Z., Zhang, Z., Zhang, L., Louie, S.G., Cherezov, V., &amp; Zhang, Y. (2024). Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labeling. <em>JACS Au</em>. https://doi.org/10.1021/jacsau.4c00695
Vancouver
Kao G, Zhang X, Nasertorabi F, Katz BB, Li Z, Dai Z, et al. Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labeling. JACS Au. 2024. doi:10.1021/jacsau.4c00695.
BibTeX
@article{guoyun2024Nicoti, title = {Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labeling}, author = {Guoyun Kao and Xiaonan Zhang and Fariborz Nasertorabi and Benjamin B. Katz and Zeyang Li and Zhefu Dai and Zeyu Zhang and Lei Zhang and Stan G. Louie and Vadim Cherezov and Yong Zhang}, journal = {JACS Au}, year = {2024}, doi = {10.1021/jacsau.4c00695}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings